Internship
Dexcom
5,001-10,000 employees
Develops continuous glucose monitoring systems
No salary listed
No H1B Sponsorship
Edinburgh, UK
You must have the Right to Work in the UK. Sponsorship is not available for this role. Priority will be given to students from the University of Edinburgh.
Get referrals →
You have ways to get a Dexcom referral from your network.
Applications through a referral are 3x more likely to get an interview!
Upload your resume to see how it matches 12 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
- Strong analytical and problem-solving skills, with an ability to work with large datasets.
- Detail-oriented, with an aptitude for financial modelling and business analysis.
- Excellent communication and collaboration skills to work with finance and cross-functional teams.
- Proficiency in Excel, Power BI, or financial software (e.g., SAP, Hyperion, Anaplan).
- Must be a currently enrolled student at a university (Year 2-4).
- Technology savvy and comfortable working with financial systems.
- Assist in financial data analysis to support business strategy and planning.
- Contribute to budgeting, forecasting, and variance analysis.
- Work with finance and business teams to improve reporting efficiency and data visualization.
- Analyze financial trends and provide recommendations to support business decisions.
- Finance studies background preferred.
Dexcom develops and markets continuous glucose monitoring (CGM) systems designed to help individuals manage diabetes. The main product, the Dexcom G6 CGM System, provides real-time glucose readings, enabling users to monitor their blood sugar levels effectively. This system consists of a small sensor placed under the skin that continuously measures glucose levels and sends the data to a smartphone or display device. Unlike traditional glucose monitoring methods that require finger pricks, Dexcom's technology offers a more convenient and less invasive way to track glucose levels. The company differentiates itself from competitors by focusing on user-friendly devices and comprehensive data analytics through its software application, Dexcom CLARITY, which helps users and healthcare providers make informed decisions based on glucose trends. The goal of Dexcom is to enhance the quality of life for diabetes patients by providing accurate and accessible glucose monitoring solutions.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
San Diego, California
Founded
1999
Simplify's Take
What believers are saying
- FDA clearance of G7 system enhances Dexcom's market credibility.
- Integration with telehealth services boosts patient engagement and adherence.
- AI integration in CGM systems improves predictive analytics and patient outcomes.
What critics are saying
- Competition from Abbott's FreeStyle Libre 3 may impact market share.
- Data privacy concerns with third-party platform integrations could deter users.
- Hiring 1000 skilled workers may strain resources and cause inefficiencies.
What makes Dexcom unique
- Dexcom G7 offers a 15-day wear period, reducing sensor replacements.
- Direct Apple Watch connectivity allows glucose monitoring without an iPhone.
- Dexcom CLARITY app provides detailed glucose patterns and trends analysis.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Professional Development Budget
Remote Work Options
Flexible Work Hours
Tuition Reimbursement
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 0%In March, cardiometabolic digital diagnostics company Nanowear announced a licensing and data partnership with Dexcom to integrate glucose data from the Dexcom G7 into its SimpleSense nanotechnology-enabled wearable.
What You Should Know:– Dexcom, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for individuals over the age of 18 with diabetes.– The Dexcom G7 15 Day system boasts an overall Mean Absolute Relative Difference (MARD) of 8.0% and builds upon the proven performance of Dexcom CGM technology, which has been clinically demonstrated to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.Dexcom G7 FeaturesThe Dexcom G7 15 Day system offers up to 15.5 days of wear allowing users to benefit from fewer monthly sensors and reduced monthly waste. The waterproof CGM system provides an overall MARD of 8.0%.Other key features of Dexcom G7 include:Apple Watch Connectivity: Direct sensor connection to Apple Watch, allowing users to view glucose numbers without their iPhone.Direct sensor connection to Apple Watch, allowing users to view glucose numbers without their iPhone. Automated Logging: Automated activity logging, simplified meal logging, and new medication logging to help users understand the impact of these factors on glucose levels.Automated activity logging, simplified meal logging, and new medication logging to help users understand the impact of these factors on glucose levels. 12-Hour Grace Period: A 12-hour grace period for sensor replacement, ensuring a smoother transition between sessions.A 12-hour grace period for sensor replacement, ensuring a smoother transition between sessions. Mobile App with Dexcom Clarity: An innovative and user-friendly mobile app with Dexcom Clarity integration for easy viewing of glucose patterns, trends, and statistics through interactive reports.An innovative and user-friendly mobile app with Dexcom Clarity integration for easy viewing of glucose patterns, trends, and statistics through interactive reports
Dexcom is preparing to launch a 15-day version of its G7 continuous glucose monitor, based on data presented Thursday at the Advanced Technologies & Treatments for Diabetes conference.
Dexcom names Masimo exec Jon Coleman as CCO.
Dexcom opening date hiring 1000 jobs as highly skilled workers wanted.